Itraconazole Dosing for Onychomycosis Treatment
Recommended Dosing Regimens
- The British Journal of Dermatology recommends itraconazole 200 mg daily for 12 weeks continuously, or alternatively as pulse therapy at 400 mg daily for 1 week per month, for onychomycosis treatment 1
- Itraconazole is optimally absorbed when taken with food and in an acidic gastric environment, according to the British Journal of Dermatology 2
- Pulse therapy offers advantages of improved compliance and potentially fewer adverse effects, as stated by the British Journal of Dermatology 1, 2
Efficacy Considerations
- The British Journal of Dermatology considers itraconazole as first-line treatment for Candida onychomycosis, with significantly greater efficacy than terbinafine 4
- Itraconazole shows cure rates of 92% compared to 40% with terbinafine for Candida onychomycosis, according to the British Journal of Dermatology 4
- The British Journal of Dermatology reports mycological and clinical relapse rates are significantly higher with itraconazole (53% and 48%) compared to terbinafine (23% and 21%) for dermatophyte onychomycosis 3
Monitoring and Safety Considerations
- Baseline liver function tests are recommended by the British Journal of Dermatology 2
- The British Journal of Dermatology advises monitoring hepatic function tests in patients with pre-existing abnormal liver function, those receiving continuous therapy for more than one month, and patients taking concomitant hepatotoxic medications 2
- Itraconazole is contraindicated in patients with heart failure or history of hepatotoxicity, according to the British Journal of Dermatology 2
Special Populations
- For pediatric patients, the recommended dose is 5 mg/kg/day as pulse therapy, with two pulses for fingernail infections and three pulses for toenail infections, as stated by the British Journal of Dermatology 5